Shocking truths about implantable cardioverter defibrillator monitoring zones
Related Experiment Video
Updated: Jul 12, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Fadi Mansour1, Bernard Thibault, Marc Dubuc
1Electrophysiology Service, Montreal Heart Institute, Montreal, Quebec, Canada.
Insights
An implantable cardioverter defibrillator (ICD) delivered an inappropriate shock due to a monitoring zone, highlighting potential risks. This case explores mechanisms and offers solutions for preventing such events in patients with hypertrophic cardiomyopathy.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Hypertrophic cardiomyopathy (HCM) necessitates implantable cardioverter defibrillators (ICDs) for primary prevention of sudden cardiac death.
- ATLAS+DR ICD systems are utilized for managing life-threatening arrhythmias.
Observation:
- A 36-year-old male with HCM experienced an inappropriate ICD shock during cycling.
- The shock occurred after sinus tachycardia, not ventricular fibrillation, with a detection threshold of 182 bpm.
- A programmed monitoring zone at 156 bpm, with morphology discriminators off, likely contributed to the event.
Findings:
- The ICD's monitoring zone, set below the ventricular fibrillation detection rate, triggered therapy inappropriately during sinus tachycardia.
- Without the monitoring zone, the device would not have delivered therapy, indicating a potential programming-related issue.
Implications:
- This case underscores the critical importance of careful ICD programming, particularly the use and settings of monitoring zones.
- Understanding these mechanisms can help clinicians troubleshoot and prevent inappropriate shocks, improving patient outcomes and device reliability.
- Further investigation into the interplay between monitoring zones and discriminators is warranted to optimize ICD therapy.
Abstract:
A 36 year-old man with hypertrophic cardiomyopathy and an ATLAS + DR implantable cardioverter defibrillator (ICD) (St. Jude Medical, Inc., St. Paul, MN, USA) for primary prevention received a shock while cycling. The ventricular fibrillation detection threshold was 182 beats/min. An additional monitoring zone was programmed to 156 beats/min with all discriminators "on" except morphology. On interrogation, the ICD shock followed sinus tachycardia. In the absence of a monitoring zone, device therapy would not have been expected. We explore the mechanisms by which monitoring zones could potentially contribute to inappropriate ICD therapy and offer trouble-shooting tips.
Related Concept Videos
Holter Monitor: 24-Hour Monitoring
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Cardiac Catheterization IV: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
